Establishment and high-throughput drug testing of multiple patient-derived cells from each renal cancer; intratumor heterogeneity of drug response and implications for precision medicine

Khalid Saeed; Poojitha Ojamies; Teijo Pellinen; Samuli Eldfors; Riku Turkki; Johan Lundin; Harry Nisen; Petrus Järvinen; Kimmo Taari; Taija af Hallstrom; Antti Rannikko; Tuomas Mirtti; Olli Kallioniemi; Paivi Ostling

doi:10.1158/1538-7445.AM2018-2199

Establishment and high-throughput drug testing of multiple patient-derived cells from each renal cancer; intratumor heterogeneity of drug response and implications for precision medicine

Khalid Saeed, Poojitha Ojamies, Teijo Pellinen, Samuli Eldfors, Riku Turkki, Johan Lundin, Harry Nisen, Petrus Järvinen, Kimmo Taari, Taija af Hallstrom, Antti Rannikko, Tuomas Mirtti, Olli Kallioniemi, Paivi Ostling

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Cancer Research
Volume	78
Issue number	13
Number of pages	2
ISSN	0008-5472
DOIs	https://doi.org/10.1158/1538-7445.AM2018-2199
Publication status	Published - Jul 2018
MoE publication type	Not Eligible
Event	Annual Meeting of the American-Association-for-Cancer-Research (AACR) - Chicago, Israel Duration: 14 Apr 2018 → 18 Apr 2018

Access to Document

10.1158/1538-7445.AM2018-2199

Cite this

Saeed, K., Ojamies, P., Pellinen, T., Eldfors, S., Turkki, R., Lundin, J., Nisen, H., Järvinen, P., Taari, K., af Hallstrom, T., Rannikko, A., Mirtti, T., Kallioniemi, O., & Ostling, P. (2018). Establishment and high-throughput drug testing of multiple patient-derived cells from each renal cancer; intratumor heterogeneity of drug response and implications for precision medicine. Cancer Research, 78(13). https://doi.org/10.1158/1538-7445.AM2018-2199

@article{44bd739b12904dc18123c89ba59bb673,

title = "Establishment and high-throughput drug testing of multiple patient-derived cells from each renal cancer; intratumor heterogeneity of drug response and implications for precision medicine",

author = "Khalid Saeed and Poojitha Ojamies and Teijo Pellinen and Samuli Eldfors and Riku Turkki and Johan Lundin and Harry Nisen and Petrus J{\"a}rvinen and Kimmo Taari and {af Hallstrom}, Taija and Antti Rannikko and Tuomas Mirtti and Olli Kallioniemi and Paivi Ostling",

year = "2018",

month = jul,

doi = "10.1158/1538-7445.AM2018-2199",

language = "English",

volume = "78",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research",

number = "13",

note = "Annual Meeting of the American-Association-for-Cancer-Research (AACR) ; Conference date: 14-04-2018 Through 18-04-2018",

}

Saeed, K, Ojamies, P, Pellinen, T, Eldfors, S, Turkki, R , Lundin, J , Nisen, H , Järvinen, P , Taari, K , af Hallstrom, T , Rannikko, A , Mirtti, T , Kallioniemi, O & Ostling, P 2018, 'Establishment and high-throughput drug testing of multiple patient-derived cells from each renal cancer; intratumor heterogeneity of drug response and implications for precision medicine', Cancer Research, vol. 78, no. 13. https://doi.org/10.1158/1538-7445.AM2018-2199

Establishment and high-throughput drug testing of multiple patient-derived cells from each renal cancer; intratumor heterogeneity of drug response and implications for precision medicine. / Saeed, Khalid; Ojamies, Poojitha; Pellinen, Teijo et al.
In: Cancer Research, Vol. 78, No. 13, 07.2018.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Establishment and high-throughput drug testing of multiple patient-derived cells from each renal cancer; intratumor heterogeneity of drug response and implications for precision medicine

AU - Saeed, Khalid

AU - Ojamies, Poojitha

AU - Pellinen, Teijo

AU - Eldfors, Samuli

AU - Turkki, Riku

AU - Lundin, Johan

AU - Nisen, Harry

AU - Järvinen, Petrus

AU - Taari, Kimmo

AU - af Hallstrom, Taija

AU - Rannikko, Antti

AU - Mirtti, Tuomas

AU - Kallioniemi, Olli

AU - Ostling, Paivi

PY - 2018/7

Y1 - 2018/7

U2 - 10.1158/1538-7445.AM2018-2199

DO - 10.1158/1538-7445.AM2018-2199

M3 - Meeting Abstract

SN - 0008-5472

VL - 78

JO - Cancer Research

JF - Cancer Research

IS - 13

T2 - Annual Meeting of the American-Association-for-Cancer-Research (AACR)

Y2 - 14 April 2018 through 18 April 2018

ER -